Related Experiment Videos
Quantification of hexokinase mRNA in mouse blastocysts by competitive reverse transcriptase polymerase chain reaction
M D Johnson1, D W Batey, B Behr
1Department of Gynecology and Obstetrics, Stanford University School of Medicine, CA 94305-5317, USA.
Molecular Human Reproduction
|April 1, 1997
Summary
This study quantifies hexokinase (HX) mRNA in mouse blastocysts, finding minute amounts. This research pioneers single-gene mRNA quantification in early embryos, crucial for understanding embryonic development and viability.
Area of Science:
- Developmental Biology
- Molecular Biology
- Biochemistry
Background:
- Hexokinase (HX) is vital for glucose metabolism in embryonic development.
- Previous studies noted variable HX gene expression in mouse embryos.
- Quantifying HX mRNA is essential to understand its role in blastocyst development.
Purpose of the Study:
- To quantify hexokinase (HX) mRNA levels in mouse blastocysts.
- To establish a method for single-gene mRNA quantification in preimplantation embryos.
- To correlate HX mRNA levels with embryonic viability and developmental competence.
Main Methods:
- Modified qualitative reverse transcription-nested polymerase chain reaction (RT-nPCR) assay.
- Competitive RT-nPCR used for HX mRNA quantification.
- Mouse blastocysts cultured in human tubal fluid (HTF) media.
Main Results:
- Mouse blastocysts express HX mRNA in minute quantities.
- Average HX mRNA amount quantified at 1.95 x 10(-18) g.
- This marks the first quantification of single-gene mRNA in preimplantation embryos.
Conclusions:
- The study established a novel method for quantifying specific mRNA in early embryos.
- HX mRNA is present in low amounts in mouse blastocysts.
- Future research can correlate these findings with embryo viability and developmental potential.